Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells

Nicotine and Tobacco Research

Volumn 9, Issue 8, 2007, Pages 793-799

  Ambrose, Vikki ^a   Miller, John H ^b   Dickson, Stuart J ^a   Hampton, Scott ^a   Truman, Penelope ^a   Lea, Rodney A ^a   Fowles, Jefferson ^a  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EPIBATIDINE; NICOTINE; NICOTINIC RECEPTOR; TOBACCO SMOKE;

ACUTE TOXICITY; ARTICLE; BINDING COMPETITION; CHRONIC TOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MITOSIS INHIBITION; NERVE CELL CULTURE; NEUROBLASTOMA CELL; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; SCATCHARD PLOT; TOBACCO DEPENDENCE;

BINDING SITES; CELL LINE, TUMOR; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MEMBRANE POTENTIALS; NEUROBLASTOMA; NICOTINE; NICOTINIC AGONISTS; PATCH-CLAMP TECHNIQUES; RECEPTORS, NICOTINIC; UP-REGULATION;

EID: 34547606246     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200701485117     Document Type: Article

References (23)

1. Baldinger, B., Hasenfratz, M. and Battig, K. (1995) Switching to ultralow nicotine cigarettes: Effects of different tar yields and blocking of olfactory cues. Pharmacology, Biochemistry, and Behavior, 50, pp. 233-239.
2. Belluzzi, J. D., Wang, R. and Leslie, F. M. (2005) Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology, 30, pp. 705-712.
3. Breese, C. R., Marks, M. J., Logel, J., Adams, C. E., Sullivan, B., Collins, A. C. and Leonard, S. (1997) Effect of smoking history on [3H]-nicotine binding in human post-mortem brain. Journal of Pharmacology and Experimental Therapeutics, 282, pp. 7-13.
4. Buisson, B. and Bertrand, D. (2002) Nicotine addiction: The possible role of functional up-regulation. Trends in Pharmacological Sciences, 23, pp. 130-136.
5. Castagnoli, K., Petzer, J. B., Steyn, S. J., van der Schyf, C. J. and Castagnoli, N. Jr. (2003) Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration. Inflammopharmacology, 11, pp. 183-188.
6. Cherek, D. R., Bennett, R. H., Kelly, T. H., Steinberg, J. L. and Benowitz, N. L. (1989) Effects of nicotine gum and tobacco smoking on human avoidance responding. Pharmacology, Biochemistry, and Behavior, 32, pp. 677-681.
7. Dunckley, T. and Lukas, R. J. (2003) Nicotine modulates the expression of a diverse set of genes in the neuronal SH-SY5Y cell line. Journal of Biological Chemistry, 278, pp. 15633-15640.
8. Gentry, C. L. and Lukas, R. J. (2002) Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Current Drug Targets CNS and Neurological Disorders, 1, pp. 359-385.
9. Gorbounova, O., Svensson, A.-L., Jonsson, P., Mousavi, M., Miao, H., Hellstrom-Lindahl, E. and Nordberg, A. (1998) Chronic ethanol treatment decreases [3H]epibatidine and [3H]nicotine binding and differentially regulates mRNA levels of nicotinic acetylcholine receptor subunits expressed in M10 and SH-SY5Y neuroblastoma cells. Journal of Neurochemistry, 70, pp. 1134-1142.
10. Groot-Kormelink, P. J. and Luyten, W. H. (1997) Cloning and sequence of full-length cDNAs encoding the human neuronal nicotinic acetylcholine receptor (nAChR) subunits β3 and β4 and expression of seven nAChR subunits in the human neuroblastoma cell line SH-SY5Y and/or IMR-32. FEBS Letters, 400, pp. 309-314.
11. Hauptmann, N. and Shih, J. C. (2001) 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity. Life Sciences, 68, pp. 1231-1241.
12. Herraiz, T. and Chaparro, C. (2005) Human monoamine oxidase is inhibited by tobacco smoke: Beta-carboline alkaloids act as potent and reversible inhibitors. Biochemical and Biophysical Research Communications, 326, pp. 378-386.
13. Kunin, D., Latendresse, M. W., Gaskin, S., Smith, B. R. and Amit, Z. (2000) Pre-exposure effects of nicotine and acetaldehyde on conditioned taste aversion induced by both drugs. Pharmacology, Biochemistry, and Behavior, 66, pp. 695-699.
14. Lena, C. and Changeux, J. P. (1998) Allosteric nicotinic receptors, human pathologies. Journal of Physiology, 92, pp. 63-74.
15. Martin-Ruiz, C. M., Court, J. A., Molnar, E., Lee, M., Gotti, C., Mamalaki, A., Tsouloufis, T., Tzartos, S., Ballard, C., Perry, R. H. and Perry, E. K. (1999) α4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. Journal of Neurochemistry, 73, pp. 1635-1640.
16. Mendez-Alvarez, E., Soto-Otero, R., Sanchez-Sellero, I. and Lamas, M. Lopez-Rivadulla (1997) Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke. Life Sciences, 60, pp. 1719-1727.
17. Mugnaini, M., Garzotti, M., Sartori, I., Pilla, M., Repeto, P., Heidbreder, C. A. and Tessari, M. (2006) Selective down-regulation of [(125)I]Y(0)-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine. Neuroscience, 137, pp. 565-572.
18. Nishizaki, T., Matsuoka, T., Nomura, T., Kondoh, T., Watabe, S., Shiotani, T. and Yoshii, M. (2000) Presynaptic nicotinic acetylcholine receptors as a functional target of nefiracetam in inducing a long-lasting facilitation of hippocampal neurotransmission. Alzheimer Disease and Associated Disorders, 14, pp. S82-S94.
19. Påhlman, S., Mamaeva, S., Meyerson, G., Mattsson, M., Bjelfman, C., Örtoft, E. and Hammerling, U. (1990) Human neuroblastoma cells in culture: A model for neuronal cell differentiation and function. Acta Physiologica Scandinavia, 592, pp. 25-37.
20. Ridley, D. L., Pakkanen, J. and Wonnacott, S. (2002) Effects of chronic drug treatments on increases in intracellular calcium mediated by nicotinic acetylcholine receptors in SH-SY5Y cells. British Journal of Pharmacology, 135, pp. 1051-1059.
21. Ridley, D. L., Rogers, A. and Wonnacott, S. (2001) Differential effects of chronic drug treatment on α3 and α7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells. British Journal of Pharmacology, 133, pp. 1286-1295.
22. Vallejo, Y. F., Buisson, B., Bertrand, D. and Green, W. N. (2005) Chronic nicotine exposure up-regulates nicotinic receptors by a novel mechanism. Journal of Neuroscience, 25, pp. 5563-5572.
23. Xiao, Y. and Kellar, K. J. (2004) The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells. Journal of Pharmacology and Experimental Therapeutics, 310, pp. 98-107.